Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zepp Health (ZEPP) Income towards Parent Company: 2016-2025

Historic Income towards Parent Company for Zepp Health (ZEPP) over the last 9 years, with Sep 2025 value amounting to $711,000.

  • Zepp Health's Income towards Parent Company rose 106.32% to $711,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year increase of 45.97%. This contributed to the annual value of -$71.6 million for FY2024, which is 122.36% down from last year.
  • As of Q3 2025, Zepp Health's Income towards Parent Company stood at $711,000, which was up 115.41% from -$4.6 million recorded in Q2 2025.
  • In the past 5 years, Zepp Health's Income towards Parent Company ranged from a high of $301.3 million in Q4 2022 and a low of -$162.1 million during Q1 2023.
  • For the 3-year period, Zepp Health's Income towards Parent Company averaged around -$9.4 million, with its median value being -$4.6 million (2025).
  • As far as peak fluctuations go, Zepp Health's Income towards Parent Company spiked by 2,038.95% in 2022, and later plummeted by 454.16% in 2024.
  • Over the past 5 years, Zepp Health's Income towards Parent Company (Quarterly) stood at $14.1 million in 2021, then skyrocketed by 2,038.95% to $301.3 million in 2022, then crashed by 97.73% to $6.8 million in 2023, then decreased by 10.96% to $6.1 million in 2024, then spiked by 106.32% to $711,000 in 2025.
  • Its Income towards Parent Company stands at $711,000 for Q3 2025, versus -$4.6 million for Q2 2025 and -$16.9 million for Q1 2025.